The scope of topics at this virtual conference, usually held in Kraków, Poland, will cover general neurobiology, cognitive and affective neuroscience, as well as clinical neurology. Ewa Sokolowska, Transpharmation’s Polish senior scientist will have her work on show, which goes beyond the standard study; Behavioural assessment of acute and a long-term antidepressant and anxiolytic efficacy in mice. For details of this study please contact us. To see our preclinical services in this therapeutic area please click here.
We are looking forward to entering this sell out virtual inflammasome therapeutics summit https://bit.ly/2J8g17f to hear from
leading experts around the world, dedicated to overcoming challenges in developing clinically effective
inflammasome therapeutics. Thank you to Inflammasome Therapeutics, GSK, and Novartis for putting it on.
The study of Alzheimer’s Disease is one of a wide range of Transpharmation’s preclinical specialisms. We are looking forward to having a recorded presentation of a recent study showing at the 21st International Conference on Alzheimer's Drug Discovery; ‘Peripheral Blood Mononuclear Cells (PBMCs): Implications for screening novel anti-inflammatories in Alzheimer’s Disease (AD).’ Please see here for further detail: publications / preclinical services. Please feel free to contact us about how we might be able to help you with your Alzheimer’s Disease studies.
The ECNP Congress Virtual is live from 12th - 15th September. This global event connects psychiatrists, neuroscientists and neurologists. Transpharmation will be joining the event and unveiling our latest study 'Chronic social defeat mouse model; in pursuit of biomarkers for depression', a stress-induced animal model of depression with high construct, face and predictive validity. It's a huge event with almost 200 world-class speakers and over 850 e-poster presentations, live and on-demand. Read more - https://www.ecnp.eu/Congress2020/ECNPcongress
The first International Association for the Study of Pain, (IASP) virtual conference is live! If you haven’t registered, please use this link https://www.eventscribe.com/2020/IASP-Virtual-Series-on-Pain/ We are delighted to be taking part by being one of the event sponsors and hosting a booth to showcase our latest work on pain. There are networking rooms and a range of topical workshops to attend https://www.eventscribe.com/2020/IASP-Virtual-Series-on-Pain/agenda.asp?pfp=FullSchedule We look forward to seeing you there!
Transpharmation will be attending this virtual event. Neuroinflammation has become an important area for us as pharma and biotech companies increasingly see neuroimmunology and neuroinflammation as a target for the development of novel treatments for neurodegenerative diseases. Our recent work on the development of in vivo and in vitro models of LPS-induced neuroinflammation using multiplexed cytokine and chemokine analysis as an end point, offers a high-throughput and translational way of evaluating novel therapeutics.
AAIC has become a regular meeting on our calendar and this year we are showcasing our latest assay - ‘Establishment of a reversal learning assay in rats to investigate the effects of novel compounds on executive function’. This expands on our well-established cognition platform and brings a new translational aspect to our portfolio.
11th May to 12th May 2020, London, United Kingdom.
Transpharmation were pleased to join this virtual event. For details of our work in this area please go to publications.
For more information please visit: https://www.smi-online.co.uk/pharmaceuticals/uk/pain-therapeutics